[EN] ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS<br/>[FR] DÉRIVÉS D'ISOXAZOLOPYRIDINE DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT D'ÉTATS À MÉDIATION PAR HIF
申请人:FIBROGEN INC
公开号:WO2009073669A1
公开(公告)日:2009-06-11
The present invention relates to novel compounds of formula (I) capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.
ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS
申请人:Arend Michael P.
公开号:US20100303928A1
公开(公告)日:2010-12-02
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.